Prof Research published a new market report on the immunology drug market. It presents the largest 16 manufacturers in the immunology drug market. The report is a professional and in-depth study on the current state of the global immunology drug market. The report provides key statistics on the market of immunology drug. It is a valuable source of guidance and direction for companies and individuals interested in the immunology drug industry.

The global immunology drug market was valued to be 138,030 million USD in 2021. The immunology drug production value is anticipated to have grown with a CAGR of 7.62% in the coming years to reach 214,421 million USD in 2027.

AbbVie is the largest manufacturer of immunology drug in the world, it has a market share of 18.3% in value. AbbVie operates as a single global business segment dedicated to the research and development, manufacturing, commercialization and sale of innovative medicines and therapies.

Johnson & Johnson is the second-largest manufacturer of immunology drug in the world, it has a market share of 12.1% in value.  It is operating in three business segments, Consumer Health, Pharmaceutical and Medical Devices.

Roche is the third-largest manufacturer of immunology drug in the world, it has a market share of 5.5% in value. The Group has two divisions, Pharmaceuticals and Diagnostics.

Biogen is the fourth largest manufacturer of immunology drug in the world, it has a market share of 4.4% in value. They operate as one operating segment, focused on discovering, developing and delivering worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies.